Page 1427 - Hall et al (2015) Principles of Critical Care-McGraw-Hill
P. 1427
4 References
110. Pichette V, Leblanc M, Bonnardeaux A, et al. High dialysate flow 128. Perel P, Roberts I. Colloids versus crystalloids for fluid resusci-
rate continuous arteriovenous hemodialysis: a new approach for tation in critically ill patients. Cochrane Database of Systematic
the treatment of acute renal failure and tumor lysis syndrome. Reviews, Issue 6. Art. No.: CD000567. DOI: 10.1002/14651858.
Am J Kidney Dis. 1994;23:591. CD000567.pub5, 2012.
111. Chugh KS, Singhal PC, Shamra BK, et al. Acute renal failure of 129. Myburgh JA, Mythen MG. Resuscitation fluids. N Engl J Med.
obstetric origin. Obstet Gynecol. 1976;48:642. 2013;369(13):1243-1251.
112. Kleinknecht D, Grunfeld JP, Gomez PC, et al. Diagnostic 130. DeBacker D, Biston P, Devriendt J, et al. Comparison of dopa-
procedures and long-term prognosis in bilateral renal cortical mine and norepinephrine in the treatment of shock. N Engl J
necrosis. Kidney Int. 1973;4:390. Med. 2010;362:779-789.
113. Ferris TF. Postpartum renal insufficiency. Kidney Int. 1978;14:383. 131. Russell J, Walley K, Singer J, et al. Vasopressin versus norepi-
114. Salerno F, Gerbes A, Gines P, et al. Diagnosis, prevention nephrine infusion in patients with septic shock. N Engl J Med.
and treatment of hepatorenal syndrome in cirrhosis. Gut. 2008;358:877-887.
2007;56:1310-1318. 132. van den Berghe G, Wouters P, Weekers F, et al. Intensive
115. Arroyo V, Guevara M, Gines P. Hepatorenal syndrome in insulin therapy in the critically ill patients. N Engl J Med.
cirrhosis: pathogenesis and treatment. Gastroenterology. 2001;345(19):1359-1367.
2002;122:1658. 133. Thomas G, Rojas M, Epstein S, et al. Insulin therapy and acute
116. Nadim M, Kellum J, Davenport A, et al. Hepatorenal syndrome: kidney injury in critically ill patients a systematic review.
the 8th international consensus conference of the Acute Dialysis Nephrol Dial Transplant. 2007;22:2849-2855.
Quality Initiative (ADQI) Group. Crit care. 2012;16:R23. 134. Wiener R, Wiener D, Larsson R. Benefits and risks of tight
117. Uriz J, Ginès P, Cardenas A, et al. Terlipressin plus albumin glucose control in critically ill adults: a meta-analysis. JAMA.
infusion: an effective and safe therapy of hepatorenal syndrome. 2008;300(8):933-944.
J Hepatol. 2000;33:43-48. 135. NICE-SUGAR study investigators. Intensive versus conven-
118. Ortega R, Ginès P, Uriz J, et al. Terlipressin therapy with and with- tional glucose control in critically ill patients. N Engl J Med.
out albumin for patients with hepatorenal syndrome: results of a 2009;360:1283-1297.
prospective nonrandomized study. Hepatology. 2002;36:941-948. 136. Ho K, Sheridan D. Meta-analysis of frusemide to prevent or
119. Testino G, Ferro C, Sumberaz A, et al. Type-2 hepatorenal treat acute renal failure. BMJ. 2006;333:420.
syndrome and refractory ascites: role of transjugular intra- 137. Ho KM, Power BM. Benefits and risks of furosemide in acute
hepatic portosystemic stent-shunt in eighteen patients with kidney injury. Anaesthesia. 2010;65:283-293.
advanced cirrhosis awaiting orthotopic liver transplantation. 138. Shilliday IR, Quinn KJ, Allison ME. Loop diuretics in the
Hepatogastroenterology. 2003;50:1753-1755. management of acute renal failure: a prospective, double-blind,
120. Guevara M, Gines P, Bandi J, et al. Transjugular intrahepatic placebo-controlled, randomized study. Nephrol Dial Transplant.
portosystemic shunt in hepatorenal syndrome: effects on renal 1997;12:2592.
function and vasoactive systems. Hepatology. 1988;28:416-422. 139. Anderson RJ, et al. Nonoliguric acute renal failure. N Engl J
121. Brensing KA, Textor J, Perz J, et al. Long term outcome after Med. 1977;296:1134.
transjugular intrahepatic portosystemic stent-shunt in non- 140. Mehta RL, et al. Diuretics, mortality, and nonrecovery of renal
transplant cirrhotics with hepatorenal syndrome: a phase II function in acute renal failure. JAMA. 2002;288:2547.
study. Gut. 2000;47:288-295.
141. Martin SJ, Danziger LH. Continuous infusion of loop diuret-
122. Finfer S, Bellomo R, Boyce N, et al. A comparison of albumin ics in the critically ill: a review of the literature. Crit Care Med.
and saline for fluid resuscitation in the intensive care unit. 1994;22:1323.
N Engl J Med. 2004;350:2247.
142. Felker M, Lee K, Bull D, et al. Diuretic strategies in patients
123. Sort P, et al. Effect of intravenous albumin on renal impairment with acute decompensated heart failure. N Engl J Med. 2011;364:
and mortality in patients with cirrhosis and spontaneous bacte- 797-805.
rial peritonitis. N Engl J Med. 1999;341:403.
143. Schetz M. Should we use diuretics in acute renal failure? Best
124. Brunkhorst F, Engels C, Bloos F, et al. Intensive insulin therapy Pract Res Clin Anaesthesiol. 2004;18:75.
and pentastarch resuscitation in severe sepsis. N Engl J Med.
2008;358:125-139. 144. Bonventre JV, Weinberg JM. Kidney preservation ex vivo for
transplantation. Annu Rev Med. 1992;43:523.
125. Dickenmann M, Oettl T, Mihatsch MJ. Osmotic nephrosis:
acute kidney injury with accumulation of proximal tubular 145. Better OS, et al. Mannitol therapy revisited (1940-1997). Kidney
lysosomes due to administration of exogenous solutes. Am J Int. 1997;52:886.
Kidney Dis. 2008;51:491-503. 146. Visweswaran P, Massin EK, Dubose TD. Mannitol-induced
acute renal failure. J Am Soc Nephrol. 1997;8:1028.
126. Hüter L, Simon TP, Weinmann L, et al. Hydroxyethylstarch
impairs renal function and induces interstitial proliferation, 147. Conger JD, Falk SA, Hammond WS. Atrial natriuretic peptide
macrophage infiltration and tubular damage in an isolated renal and dopamine in established acute renal failure in the rat.
perfusion model. Crit Care. 2009;13(1):R23. Kidney Int. 1991;40:21.
127. Myburgh J, Finfer S, Bellomo R, et al. Hydroxyethyl starch or 148. Rahman SN, Kim GE, Mathew AS, et al. Effects of atrial
saline for fluid resuscitation in intensive care. N Engl J Med. natriuretic peptide in clinical acute renal failure. Kidney Int.
2012;367:1901-1911. 1994;45:1731.
Section08-O-Ref.indd 4 12/10/2014 6:08:07 PM

